Benecchi Christopher (CIK 1881403) reported 8 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2025-07-31). Recent activity: Sell SAGE (28,053 shares), Sell SAGE (36,375 shares), Buy SAGE (3,255 shares), Sell SAGE (793 shares), Buy SAGE (2,712 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-07-31 | Sage Therapeutics, Inc. (SAGE) | Chief Operating Officer | Sell | 28,053 | $0 |
| 2025-07-31 | Sage Therapeutics, Inc. (SAGE) | Chief Operating Officer | Sell | 36,375 | $0 |
| 2025-04-11 | Sage Therapeutics, Inc. (SAGE) | Chief Operating Officer | Buy | 3,255 | $0 |
| 2025-04-11 | Sage Therapeutics, Inc. (SAGE) | Chief Operating Officer | Sell | 793 | $5,480 |
| 2025-04-11 | Sage Therapeutics, Inc. (SAGE) | Chief Operating Officer | Buy | 2,712 | $0 |
| 2025-04-11 | Sage Therapeutics, Inc. (SAGE) | Chief Operating Officer | Sell | 661 | $4,568 |
| 2025-02-14 | Sage Therapeutics, Inc. (SAGE) | Chief Operating Officer | Sell | 822 | $5,902 |
| 2025-01-21 | Sage Therapeutics, Inc. (SAGE) | Chief Operating Officer | Buy | 20,000 | $0 |
Source: SEC Form 4 filings · as of 2025-07-31